Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Benign Prostatic Hyperplasia Treatment Companies

Benign Prostatic Hyperplasia (BPH) is a common condition among aging men, characterized by the enlargement of the prostate gland, leading to urinary symptoms. companies specialize in developing innovative and effective treatments for BPH, aiming to enhance the quality of life for individuals affected by this condition.

Benign Prostatic Hyperplasia Treatment Key Companies

Latest Benign Prostatic Hyperplasia Treatment Companies Update:

Urotronic announces positive results from the PINNACLE clinical trial: The trial assessed the Optilume BPH System, a minimally invasive device combining mechanical dilation and paclitaxel delivery, showing significant improvements in urinary flow and symptom relief compared to sham procedure.

Teleflex expands its UroLift System reach to Japan: This FDA-approved system for BPH relief through tissue lifting utilizes tiny implants, offering a minimally invasive and effective alternative to traditional surgery.

Boston Scientific acquires NxThera, bolstering its BPH treatment portfolio: This acquisition brings NxThera's novel Prostatic Artery Embolization (PAE) technology for BPH treatment under Boston Scientific's umbrella, diversifying its offerings and catering to wider patient needs.

List of Benign Prostatic Hyperplasia Treatment Key companies in the market

Air Liquide

Abbott Laboratories

AbbVie (Allergan Plc)

Astellas Pharma Inc.

Boehringer Ingelheim Pharma GmbH & Co. KG

Eli Lilly and Company

GlaxoSmithKline plc.

Merck & Co., Inc. (Merck Sharp & Dohme Corp)

Pfizer Inc.

Sanofi

Teva Pharmaceutical Industries Limited

Benign Prostatic Hyperplasia Treatment Market Highlights:

Benign Prostatic Hyperplasia Treatment Market Size

Benign Prostatic Hyperplasia Treatment Market Trends

Benign Prostatic Hyperplasia Treatment Market Analysis

Benign Prostatic Hyperplasia Treatment Market Share

Benign Prostatic Hyperplasia Treatment Market Highlights:

Benign Prostatic Hyperplasia Treatment Market Trends

Benign Prostatic Hyperplasia Treatment Market Analysis

Benign Prostatic Hyperplasia Treatment Market Share

Benign Prostatic Hyperplasia Treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.